D
DocOxRedox
Member
- Feb 25, 2024
- 20
- 9
Pros- Great CS, solid communication, and viable products.
BPC157 / TB500 250mcg/day
-Testing in soft tissue with known specific pathology, including tears, inflammatory enthesitis, and chronic degeneration is confirmed.
-Marked reduction in localized tendon swelling followed at day 3, and what appears to be improved elasticity by day 10. Its unknown if an impact is occurring on glycoproteins, however interfascicular matrixing appears to be occurring as joints/tissue have shown improved mobility.
-Tissue stimulation at day 14 no longer triggers an acute tenosynovitis response, while a minor response is noted, severity has markedly decreased.
-Tissue response appears to be received best in target areas vs attempted systemic application.
Cons-Its not free
Thats about it. Everyone has the opinion on applications and methodologies but research will continue as needed to fully assess the potential benefits of said products.
BPC157 / TB500 250mcg/day
-Testing in soft tissue with known specific pathology, including tears, inflammatory enthesitis, and chronic degeneration is confirmed.
-Marked reduction in localized tendon swelling followed at day 3, and what appears to be improved elasticity by day 10. Its unknown if an impact is occurring on glycoproteins, however interfascicular matrixing appears to be occurring as joints/tissue have shown improved mobility.
-Tissue stimulation at day 14 no longer triggers an acute tenosynovitis response, while a minor response is noted, severity has markedly decreased.
-Tissue response appears to be received best in target areas vs attempted systemic application.
Cons-Its not free
Thats about it. Everyone has the opinion on applications and methodologies but research will continue as needed to fully assess the potential benefits of said products.
Who is viewing this thread?
There are currently 0 members watching this topic